Related references
Note: Only part of the references are listed.A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers
Michelle J. Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers
Eungi Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer
Ruo-Kai Lin et al.
LUNG CANCER (2007)
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy
Farnaz Taghizadeh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein
JF DiMartino et al.
LEUKEMIA (2006)
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix
A Chlenski et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis
P Sova et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
5-Aza-2 '-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation
SA Scott et al.
LEUKEMIA RESEARCH (2006)
Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis
N Said et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Survey of differentially methylated promoters in prostate cancer cell lines
YP Wang et al.
NEOPLASIA (2005)
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
IT Tai et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
被撤回的出版物: Aberrant methylation of SPARC in human lung cancers (Retracted article. See vol. 108, pg. 744, 2013)
M Suzuki et al.
BRITISH JOURNAL OF CANCER (2005)
Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16(INK4A) promoter in colon carcinoma cell lines
C Mund et al.
NUCLEIC ACIDS RESEARCH (2005)
Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia
S Lee et al.
LABORATORY INVESTIGATION (2004)
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions
N Sato et al.
ONCOGENE (2003)
Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model
JN Rich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Enhanced growth of tumors in SPARC null mice is associated with changes the ECM
RA Brekken et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Doxycycline-inducible expression of SPARC/osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition
N Dhanesuan et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells
WG Zhu et al.
ONCOGENE (2001)
SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells
GK Yiu et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury
AD Bradshaw et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
MS Soengas et al.
NATURE (2001)
The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
DC Chung
GASTROENTEROLOGY (2000)
CpG methylation is maintained in human cancer cells lacking DNMT1
I Rhee et al.
NATURE (2000)
Share Paper
